-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The accumulation of ectopic lipids in the kidneys (fatty kidneys) is a potential driving factor for diabetic nephropathy.
Strict blood sugar control can reduce the risk of diabetic nephropathy
.
This study evaluated whether blood glucose control affects the renal triglyceride content ( RTGC)
.
The accumulation of ectopic lipids in the kidneys (fatty kidneys) is a potential driving factor for diabetic nephropathy.
In this single-center, parallel group trial, the 2 diabetic patients were randomized to liraglutide or placebo, and include standard therapy ( metformin / sulphonylurea derivative / insulin)
.
In this single-center, parallel group trial, the 2 diabetic patients were randomized to liraglutide or placebo, and include standard therapy ( metformin metformin / sulphonylurea derivative / insulin)
Baseline analysis included 50 embodiment 2 diabetic patients ( mean age 56.
Baseline and glycemic control results after 26 weeks, not related to the randomized treatment group
Baseline and glycemic control results after 26 weeks, not related to the randomized treatment groupResults of baseline and conventional blood glucose treatment after 26 weeks of liraglutide or placebo treatment
Results of baseline and conventional blood glucose treatment after 26 weeks of liraglutide or placebo treatmentGlycemic control in the 26 weeks after, logt transformed RTGC was -0.
68 ± 0.
Glycemic control in the 26 weeks after, logt transformed RTGC was -0.
The therapeutic effect of liraglutide and placebo on RTGC and UACR
The therapeutic effect of liraglutide and placebo on RTGC and UACRIn general , this exploratory study found that 26 weeks of blood glucose control will reduce RTGC, especially liraglutide
.
Overall , this exploratory study found , this exploratory study found , this exploratory study found that 26 weeks of glycemic control will reduce RTGC, especially liraglutide
https://doi.
org/10.
1053/j.
jrn.
2020.
09.
006.
Leave a message here
